Here at the ten drugs on the Medicare drug price negotiation program's list, and when you can expect to see the massive ...

The Biden administration is taking a victory lap after federal officials inked deals with drug companies to lower the price ...

The Centers for Medicare & Medicaid Services (CMS) has said it will announce the next 15 drugs in scope for the second round ...

Tuesday's Senate Committee on Finance hearing on the Inflation Reduction Act (IRA) featured both proponents and critics of ...

Three Motley Fool contributors think they've identified dirt-cheap healthcare stocks to buy right now. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Gilead Sciences (NASDAQ: GILD), and ...

Both are essential in treating conditions caused by blood clots such as heart attack and stroke, but they work in different ...

Results from Medicare’s first year of negotiation with other price benchmarks shed light on the competitive dynamics and ...

Taxpayers spend more than $50 billion yearly on the 10 drugs, which include popular blood thinners Xarelto and Eliquis and ...

Pfizer PFE stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has ...

The soaring cost of common blood clot medicine is “financially crippling” local pharmacies in Northern Ireland, according to ...

Doctors and pharmacists treating people with blood thinners can reduce the rate of inappropriate dosing -; as well as blood clots and strokes that can result from it -; using an electronic patient ...

Since herbal supplements are often marketed as natural remedies for a variety of health conditions, many people mistakenly ...